$8.18
-0.11[-1.33%]
At close: Apr 19
$8.18
0[0.00%]
After Hours: 5:10PM EDT
Outlook Therapeutics
(NASDAQ:OTLK)Latest News for Outlook Therapeutics Stock (NASDAQ:OTLK)
Outlook Therapeutics Stock (NASDAQ: OTLK)
Categories: All
Friday, April 12, 2024
Monday, April 01, 2024
Thursday, March 28, 2024
Wednesday, March 27, 2024
Monday, March 25, 2024
Friday, March 22, 2024
- Gold Moves Lower; Lululemon Shares PlummetAvi Kapoor - Mar 22, 2024, 2:50PM
- Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Mar 22, 2024, 2:39PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Mar 22, 2024, 1:31PM
- Dow Dips 200 Points; Nike Shares Fall After Q3 ResultsAvi Kapoor - Mar 22, 2024, 12:18PM
- Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Higher On Friday?Vandana Singh - Mar 22, 2024, 10:51AM
- Outlook Therapeutics shares are trading higher after the company announced it received a positive European Union CHMP opinion for ONS-5010 as a treatment for Wet AMD.Benzinga Newsdesk - Mar 22, 2024, 9:20AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Mar 22, 2024, 9:06AM
- Market-Moving News for March 22ndBenzinga Newsdesk - Mar 22, 2024, 8:33AM
- On 21 March 2024, EU's CHMP Adopted A Positive Opinion, Recommending The Granting Of A Marketing Authorization For Outlook Therapeutics' Lytenava, Intended For Treatment Of Neovascular Age-related Macular DegenerationCharles Gross - Mar 22, 2024, 6:54AM
Thursday, March 14, 2024
Wednesday, March 13, 2024
Tuesday, March 12, 2024
Thursday, February 22, 2024
Thursday, February 15, 2024
Wednesday, February 14, 2024
- Outlook Therapeutics Provides Corporate Update; Formal Review Process For ONS-5010 MAA By EMA Committee For Medicinal Products For Human Use Is Underway With Decision Date In H1 2024; Explores Expanded Relationship With CencoraBenzinga Newsdesk - Feb 14, 2024, 8:17AM
- Outlook Therapeutics Q1 2024 GAAP EPS $(0.04) Beats $(0.05) EstimateBenzinga Newsdesk - Feb 14, 2024, 8:11AM
Wednesday, January 31, 2024
Thursday, January 25, 2024
Tuesday, January 23, 2024
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Jan 23, 2024, 12:31PM
- Outlook Therapeutics shares are trading higher after the company announced it received FDA agreement under a SPA for the NORSE EIGHT clinical trial. Also, the company announced a private placement of up to $172 million to advance ONS-5010.Benzinga Newsdesk - Jan 23, 2024, 12:09PM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Jan 23, 2024, 8:06AM
- Outlook Therapeutics Announced Private Placement Of Up To $172M To Advance ONS-5010Benzinga Newsdesk - Jan 23, 2024, 8:05AM
- Outlook Therapeutics Announces FDA Agreement Under Special Protocol Assessment For 90 Day Non-Inferiority Study, NORSE EIGHTBenzinga Newsdesk - Jan 23, 2024, 8:03AM
Friday, December 29, 2023
Wednesday, December 27, 2023
Friday, December 22, 2023
Tuesday, December 19, 2023
Wednesday, December 06, 2023
Monday, November 27, 2023
Friday, November 03, 2023
- This Analyst Upgrades Vision Disorder-Focused Outlook Therapeutics' Prospects After FDA Agreement Despite Investor ConcernsVandana Singh - Nov 3, 2023, 3:25PM
- Analyst Ratings for Outlook TherapeuticsBenzinga Insights - Nov 3, 2023, 12:00PM
- Cyberark Software To Rally Around 21%? Here Are 10 Top Analyst Forecasts For FridayLisa Levin - Nov 3, 2023, 8:11AM
- HC Wainwright & Co. Maintains Buy on Outlook Therapeutics, Raises Price Target to $2Benzinga Newsdesk - Nov 3, 2023, 7:08AM
Thursday, November 02, 2023
- Crude Oil Gains Over 2%; S&P Global Raises Profit OutlookLisa Levin - Nov 2, 2023, 2:40PM
- Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Nov 2, 2023, 2:26PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Nov 2, 2023, 1:31PM
- Why Is Retinal Disease-Focused Outlook Therapeutics Stock Plunging Today?Vandana Singh - Nov 2, 2023, 12:30PM
- Dow Jumps 400 Points; Starbucks Posts Upbeat EarningsLisa Levin - Nov 2, 2023, 12:16PM
- Outlook Therapeutics shares are trading lower after the FDA informed the company that an additional adequate and well-controlled clinical trial would be required for the approval of ONS-5010 for the treatment of wet AMD.Benzinga Newsdesk - Nov 2, 2023, 12:15PM
- Nasdaq Surges Over 1%; US Initial Jobless Claims Increase To 217,000Lisa Levin - Nov 2, 2023, 10:13AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Nov 2, 2023, 9:05AM